Control of Thymic Growth by Cowan, Jennifer E. et al.
REVIEW
published: 12 May 2020
doi: 10.3389/fimmu.2020.00897

















This article was submitted to
T Cell Biology,
a section of the journal
Frontiers in Immunology
Received: 20 February 2020
Accepted: 17 April 2020
Published: 12 May 2020
Citation:
Cowan JE, Takahama Y, Bhandoola A
and Ohigashi I (2020) Postnatal
Involution and Counter-Involution of
the Thymus. Front. Immunol. 11:897.
doi: 10.3389/fimmu.2020.00897
Postnatal Involution and
Counter-Involution of the Thymus
Jennifer E. Cowan 1*, Yousuke Takahama 2, Avinash Bhandoola 1 and Izumi Ohigashi 3*
1 Laboratory of Genome Integrity, Center for Cancer Research, National Cancer Institute, National Institutes of Health,
Bethesda, MD, United States, 2 Experimental Immunology Branch, National Cancer Institute, National Institutes of Health,
Bethesda, MD, United States, 3Division of Experimental Immunology, Institute of Advanced Medical Sciences, University of
Tokushima, Tokushima, Japan
Thymus involution occurs in all vertebrates. It is thought to impact on immune responses
in the aged, and in other clinical circumstances such as bone marrow transplantation.
Determinants of thymus growth and size are beginning to be identified. Ectopic
expression of factors like cyclin D1 and Myc in thymic epithelial cells (TEC)s results in
considerable increase in thymus size. These models provide useful experimental tools
that allow thymus function to be understood. In future, understanding TEC-specific
controllers of growth will provide new approaches to thymus regeneration.
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INTRODUCTION
The thymus is the primary site of T cell development. It is a specialized environment that fosters
the production of a diverse T cell repertoire, allowing T cells to recognize and eliminate foreign
antigen but remain tolerant to self. The thymic epithelial cells (TEC)s educate developing T
cells, where cortical (c)TECs select for those expressing functional receptors, whilst medullary
(m)TECs deplete those with potential specificity to the body’s own cells (1). TECs provide
essential signals to T cell precursors that drive their migration, differentiation, proliferation, and
survival. Correspondingly, developing thymocytes provide signals to drive TEC differentiation and
organization. This process is termed thymic crosstalk (1, 2). Impaired TEC development results in
severe T cell immunodeficiency (3–5).
THYMIC INVOLUTION
The thymus is the first organ to undergo aged-related involution and at an accelerated rate relative
to other tissue (6). The process of thymic involution is evolutionarily conserved in all vertebrates
(7). The organ undergoes rapid growth during development, peaks in size around adolescence and
begins to decline with age; with the initiation of involution beginning as early as birth and no later
than the onset of puberty in humans and mice (6). This thymic regression includes reductions in
thymic mass, loss of thymic structure, and disorganization to thymic architecture, consequently
resulting in diminished thymocyte numbers and reduced naïve T cell output (6, 8, 9). In addition
to chronic age-related involution, the thymus can undergo acute atrophy under conditions of
physiological stress, such as infection (10), pregnancy (11, 12), and cancer treatments (13).
Stressed-induced thymic involution results in decreased naïve T cell output and compromised
host immunity, and is commonly reversible, with recovery of size and function after the insult is
removed (6, 14, 15). This acute involution involves rapid reductions in proliferation and enhanced
apoptosis of developing thymocytes. These impairments in developing T cells can be a direct effect
of infection on thymocytes (16). However, acute thymic involution can also be a consequence of the
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infectious agent on TEC, which in turn drives thymocyte death
(16, 17). An example of the latter is seen with synthetic dsRNA
Poly(I:C) treatment, which mimics a viral infection and rapidly
triggers thymic involution in mice. This acute thymic atrophy is
mediated by type I IFN responses, that do not act directly on the
T cell precursors (17).
Signals between TEC and thymocytes are bi-directional, with
defects and alterations in the haemopoietic component of the
thymus also having dramatic consequences on TEC development
and maintenance. The importance of lymphoid-epithelial cell
interactions for thymic architecture was established in mice
lacking mature T cells, that present with severely impaired mTEC
development (18). Early stage blocks in T cell development, such
as in human CD3ε transgenic mice, show severely disrupted
thymic architecture and defective cTEC and mTEC development
(19), whilst mice with later stage defects in the TCR complex,
such as genetic disruptions to the TCRα gene, Rag-1 deficiency
or ZAP-70, have severely abrogated mTEC generation (19–
21). Interesting, successful reconstitution in the adult thymus
does not require thymic crosstalk in the fetal period. Thus,
adult human CD3ε transgenic mice receiving WT fetal liver
transplants had increased thymic size and restored thymic
architecture and function (22). As thymocyte-derived signals are
so essential in the establishment and maintenance of the thymic
microenvironment, a role for both lymphoid cells and epithelial
cells needs to be considered in the process of stressed-induced
and chronic age-related involution.
Many agents have been identified to be involved in
acute stress-induced thymic atrophy, including proinflammatory
cytokines, steroids, and hormones. Inhibition of such agents
can prevent this acute involution (14). The drivers of chronic
age-related involution remain less clear, and it is unknown
if the same cellular and molecular mechanisms underlie both
chronic and acute involution (6). Sex hormones, increased after
puberty, facilitate the chronic involution process, and castration
of old mice can successfully albeit transiently restore both
thymic size and function (23). Moreover, castration of young
adult mice resulted in enhanced thymic regeneration following
bone marrow transplantation (24). Sex steroid ablation can also
enhance thymic function in humans. Prostate cancer patients
undergoing sex steroid ablation therapy present with significant
increases in numbers of naive T cells as a consequence of
enhanced thymic function and T cell export (24). Although it is
still poorly understood how sex steroids drive age-related thymic
involution, atrophy is at least partially attributed to increased sex
steroids at puberty (25).
IMMUNOLOGICAL CONSEQUENCES OF
THYMIC INVOLUTION
Although aging results in widespread immunodeficiency, the
direct consequences of age-related thymic involution on
impaired immune function in the elderly is poorly understood.
Old people are more susceptible to infection, and infections
in the elderly often have higher severity compared to the
young (8). Furthermore, the elderly mount poorer responses to
vaccines (26) and show increased incidence of cancers (27). These
phenomena are suggested to be, at least in part, a consequence of
declining numbers and diversity of naive T cells emerging from
the aged thymus, which in turn contributes to the shift toward
memory phenotypes in the periphery (8, 26, 27).
Age-related thymic involution in mouse limits the numbers
of recent thymic emigrants in the periphery (28). Moreover, in
humans, using T-cell receptor excision circles (TREC) tomeasure
thymic output, generation of new T cells was minimal in the
elderly, with the frequency of TREC declining steadily with
age (29, 30), although the precise age of when this reduction
is initiated remains unclear (31). This was confirmed in a
study that acquired thymic samples in addition to peripheral
blood (32). Elderly individuals displayed a wide range of
thymic functionality, measured by the frequency of double
positive thymocytes (the higher the frequency of DP, the higher
the functionality). When thymic function was compared to
percentages of naïve T cells, reduced thymus function correlated
well with decreased naïve T cell numbers. Moreover, this
comparison identified a strong relationship between the low
functioning thymi and the contraction of naïve CD8T cells
specifically. These studies also revealed a relationship between
thymic function and the dynamics of peripheral naive T cells,
where reduced thymus function was associated with shortened
telomere length and aberrant activation and proliferation status
in naïve CD8T cells (32).
There are examples of viruses that aged mice are more
susceptible to, as a consequence of age-related alteration to T
cell responses. These include West Nile Virus, where old mice
have reduced rates of survival compared to young. This increased
susceptibility is a consequence of age-related defects in T cell
immunity, involving both CD8 and CD4T cell responses (33).
Influenza has also been identified as an age-sensitive virus. It
has been demonstrated that compromised protective immunity
in aging against influenza can be a consequence of the age-
associated decline in CD8T cell repertoire diversity, resulting in
“holes” in the repertoire that may impair the ability of T cells to
control the virus (34).
Rejuvenation of the involuted thymus restores peripheral
T cell function in aged mice and humans (24, 35). Many
agents have been identified to reverse thymic atrophy, although
their effects are only transient. Those include interleukin-7,
sex steroids, growth hormones, and keratinocyte growth factor
(KGF) (36). Sex steroid ablation can also improve immune
responses. The level of restoration, however, following castration
is limited by age, with enhancement of thymic function following
the procedure lost between 9 and 18 months. Nine-month-
old castrated males when challenged with Influenza A display
restored numbers of virus specific cytotoxic CD8T cells to levels
comparable to young mice, and improved viral clearance in
the lung (37). In contrast, 24-month-old castrated mice did
not display restored numbers of virus-specific CD8T cells to
young levels, yet still had observed reductions in lung viral
titers (37). Thus, age-associated defects in T cell immunity
may, at least in part, be attributed to the diminished naïve
T cell repertoires, and thymic regeneration by sex steroid
ablation can restore this deficiency and improve viral immune
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responses, but in an age-limited manner. Moreover, sex steroid
ablationmust be having additional T-cell independent effects that
improve viral clearance (37). Interestingly, a recent publication
has suggested that restoration of thymic size in an aging host
using sex steroid ablation or KGF does not confer protection
to the host against West Niles Virus (38). Thus, modest
increases to thymic size in aging hosts might not be sufficient
to improve immune protection. The complete contribution of
thymic involution to age-associated defects in T cell immunity
remains to be determined.
Overall the immunological consequences of age-related
thymic involution on the peripheral T cell pool potentially
leaves the elderly with compromised protective immunity
against pathogens. Thus, a better understanding of the
molecular and cellular mechanisms underlining the causes
of age-related thymic involution should offer benefits to the
aging population in multiple clinical settings. It also needs to
be considered, however, that age associated immune system
defects may also be due to the aging of the hematopoietic
cells, and not all a consequence of reduced thymic function.
The general physiological consequences of aging to the host
also needs to be considered when exploring the attributes
of compromised protection against infectious agents in
the elderly.
THE ROLE OF TECs IN THYMIC
INVOLUTION
It has been reported that the transfer of bone marrow cells or
early T cell progenitors isolated from youngmice does not restore
thymic function in aged recipients, whereas the transplantation
of fetal thymi into aged hosts exhibits thymocyte development
equivalent to a young host. Thus, indicating that thymic stromal
cells, rather than hematopoietic cells, drive thymic involution (15,
39–41). The reduction in size of the aged thymus is accompanied
with reduced TEC numbers (9). Postnatal reductions in
expression of the Forkhead box N1 (Foxn1) transcription factor
is sufficient to accelerate age related thymic involution (42,
43). Moreover, targeted overexpression of Foxn1 in adult TECs
can attenuate the involution process and delay the decline in
naïve T cells observed in the aging host (35). Foxn1 expression
is diminished in aged stroma (44), suggesting a relationship
between the decline of Foxn1 expression and age-associated
thymic involution.
It has been demonstrated that genetic ablation of cTECs
alone has profound effects on thymic size, and severely
impaired thymocyte development (45). This complements a
recent publication that explored the morphological changes
in TECs with age and suggested dramatic changes to cTEC
structure alone reduce thymic size (46). The authors genetically
labeled TECs using conditional confetti mice to facilitate the
visualization of individual TECs in cortical or medullary regions.
First it was established that cTECs in the thymus of young
mice have unique morphology, with extensive networks of
projections estimated to engulf over 100 lymphocytes within
them. Second, these cTEC projections contracted in the thymus
of 12-month mice, in contrast to mTEC morphology, that
is unaltered with age. As the authors suggest, this dramatic
alteration to cTEC morphology may contribute to thymic
involution, instead of or in addition to increased cTEC
death or decreased rates of cTEC proliferation with age
(46). This morphological characterization of adult cTECs
further offers a possible explanation as to why conventional
enzymatic digestion methods used for cTEC isolation
dramatically underestimate their cellularity in the postnatal
thymus (47).
In addition to morphological changes with age in cTECs,
their expression of Catalase, an antioxidative enzyme, is lower
compared to mTECs and lymphocytes, which results in their
increased susceptibility to oxidative damage (48). Indeed, the
morphological alteration of cTECs is greatest in the sub-capsular
cortex, which is the region of intense proliferation activity of
lymphocytes, and thus of intense metabolism (46).
Transcriptional profiling of TECs in young and aged
thymi has revealed dynamic gene profiles during the initial
involution process in both cTECs and mTECs, aiding the
understanding of the mechanisms that govern the decline
of TEC numbers with age. A transcriptional hallmark of the
initiation of involution in TECs was the downregulation of
genes involved in cell cycle, specifically diminished E2F3 activity,
suggesting possible reductions to cell cycle progression in all
aging TECs (49). The same aging-associated transcriptional
changes are seen in mTECs during the initial phase of thymic
involution, from 2 to 10 weeks of age (50). Furthermore,
gene expression profiles of cTECs display greater alterations
during involution and regeneration, than those of both
their mTEC counterparts and developing T cells (23). The
dynamic changes in cTEC transcriptomes following castration
mediated thymic regeneration revealed that genes upregulated
in expression during thymic regrowth included those
involved in cell morphology, cell adhesion, and cytoskeleton
remodeling (46).
The underlying mechanisms of the age-related decline in
TEC numbers and function that mediate thymic atrophy
remain ambiguous, although many changes to TEC biology
throughout life have been documented. The pivotal role of
TECs in the process of thymic atrophy identify them as
an attractive therapeutic target to counter thymic involution
(15). Although the morphological, metabolic and transcriptional
alterations with age are more prevalent in cTECs, the significance
of this has yet to be determined. One major constraint of
conclusively identifying a role for cTECs in age-associated
thymic involution is the limitation in the numbers of cTECs
able to be isolated from the adult thymus. We hope the
enlarged thymus models discussed in this review will provide
useful experimental tools to isolate greater numbers of adult
cTECs to perform more detailed analysis of the changes that
occur in this population with age. In addition, the newly
refined genetic models described below will facilitate the ectopic
expression of Myc specifically in cTEC or mTEC subsets
(51). This could potentially determine whether such targeted
manipulation is sufficient to reverse involution and force
thymus growth.
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TECs MEDIATE CHANGES TO THYMIC
SIZE THROUGHOUT LIFE
In addition to controlling thymic atrophy, TECs regulate all
changes in thymic size observed throughout life. This includes
the dramatic increase seen during mouse embryogenesis, when
the thymus doubles in size daily, and the continued expansion,
although at a reduced rate, until 4 weeks of age, when thymic
cellularity peaks. TECs also maintain this maximal size until
around 8 weeks of age, when involution is initiated (9). Defects
in TEC development and numbers results in diminished thymic
size (52). Moreover, dramatic expansion in TEC numbers in
adulthood results in simultaneous expansion in the numbers
of developing lymphocytes and severe thymic hyperplasia
(51, 53–55). Correspondingly, and as mentioned previously,
postnatal disruption of TECs triggers accelerated thymic atrophy
(42, 43). Furthermore, restricting the Foxn1 dependent TEC
progenitors results in reduced thymic size during the initial
formation of the thymus, and this persists into the adult
period (56).
The rapid expansion in thymic size and TEC number during
fetal and neonatal life is supported by TECs having unique
properties that distinguish them from postnatal populations.
This includes higher rates of proliferation (9, 51) and ribosomal
biogenesis (51). Additionally, fetal TECs are functionally distinct
compared to their adult counterparts. This includes their
ability to undergo successful engraftment following intra-
thymic injection into an adult host, a property lost after
birth (57). In addition, fetal TECs have an exclusive ability
to support development of fetal waves of gamma delta T
cells (58). Moreover, it has also been suggested that TEC
progenitors in the fetal and postnatal thymus differ. TECs
in the adult thymus have a turnover rate of ∼2 weeks (9),
yet their putative self-renewal capacity and precursor- product
relationships remain unclear (1, 2). A common bipotent TEC
progenitor has been identified at E13.5 that can give rise
to both cTECs and mTECs (59, 60). During initial thymus
formation, TEC progenitors can first acquire some cTEC
specific markers, before differentiating into the mTEC lineage
(2, 61), but mTEC lineage restricted progenitors have also been
identified in the fetal thymic environment (62). Corresponding
progenitor populations in the adult thymus remain to be
determined (2).
Myc ACTIVITY IN TECs IS LIMITING FOR
THYMIC SIZE AND FUNCTION
Understanding the transcriptional controllers of fetal TECs and
how they support the rapid expansion in thymic size during
embryogenesis offers insight intomechanisms underlying thymic
function and regeneration. Recently, transcriptional assessment
of TECs through development at a single cell resolution has
revealed distinct transcriptional programs of TECs at specific
stages of life (51, 63–65). This included the identification of
a fetal specific program comprising high levels of expression
of Myc target genes, including cell cycle genes and genes
involved in ribosomal biogenesis. Such genes displayed declining
expression in TECs through fetal development, coordinated
with reduced expression of Myc protein. Transcript levels
corresponded with declining rates of cell proliferation and
correlates of ribosomal biogenesis in TECs through development.
It was hypothesized that this high Myc activity in fetal
TECs drives the expansion in TEC numbers and consequently
thymic size during early development (Figure 1A) (51). It has
previously been reported that mice with conditional removal
of Myc in TECs present with small thymi in adulthood, as a
consequence of reduced rates of proliferation and decreased
TEC numbers (66). Consistently, enhancing Myc expression
in TECs resulted in a severe increase in TEC number and
dramatic thymic hyperplasia in adulthood (Figure 1B). This
continued Myc expression in TECs conferred expression of
a fetal-specific transcriptional program, including high levels
of expression of genes involved in cell cycle and ribosomal
biogenesis (51). Interestingly, this ribosomal signature was
unique to the Myc model, as another transgenic large thymus
model, driven by cell cycle gene cyclin D1, did not present
with increased transcripts of genes involved ribosomal biogenesis
(51, 67).
The dramatic thymic growth conferred by the Myc
transgene did not jeopardize function, similar to previous
reports with cyclin D1 transgenic mice (53, 54), and
such enlarged thymi also produced increased numbers of
recent thymic emigrants. Furthermore, this continued Myc
expression preserved the ability of TECs to engraft following
intrathymic injection into adulthood. Myc overexpression
did not need to be maintained throughout life to increase
thymic size, with inducible expression of Myc in adult and
aged TECs being sufficient to similarly promote thymic
growth (Figure 1C). Although the decline in Myc activity
was most striking between fetal and adult TECs, the same
reductions, but at much more modest rates, could be
detected transcriptionally between adult and aged cTEC
populations (51). Thus, this decline in Myc activity in TECs
could underlie the reduction in thymic cellularity observed
during involution.
Collectively, these results identify Myc as a major regulator
of a fetal specific transcriptional program of TECs. They
establish a role for Myc activity in rapid thymic growth
during development; provide evidence Myc expression
can confer at least one functional distinct property of
fetal TECs into adulthood and furthermore, confirm that
Myc activity is limiting for thymic size and function (51).
Upstream controllers of Myc in TECs remain to be identified
and are logical candidates in modulating thymic function
and regeneration.
In addition to unique transcriptional profiles of fetal
TECs, the adult TECs were highly enriched for genes
involved in antigen processing and presentation, along
with regulation of the actin cytoskeleton and the lysosomes
(51). Our results suggest an adult specific transcriptional
program of TECs supports the maintenance of a functional
thymus in adulthood, complementing and extending previous
work (49, 63, 64).
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FIGURE 1 | Myc activity in TEC limits thymic size. (A) Thymic size (black line) and Myc activity in TECs (green line) during a WT mouse life span. X axis represents age,
from day of fertilization. B/C. Thymic size (black line) and Myc activity in TECs (green line) during a FoxN1 MycTg mouse (B) or an inducible MycTg mouse (C) life span.
CYCLIN D1 OVEREXPRESSION IN THYMIC
EPITHELIAL CELLS ENLARGES
FUNCTIONAL THYMUS
Cyclin family molecules are key regulators for cell cycle
progression that control the number of cells and the size of
organs. Cyclin proteins associate and activate cyclin-dependent
kinases (CDKs), serine/threonine kinases, important for the
progression of cell cycle (68). Approximately 30 members of
cyclin family proteins, defined by the cyclin box domain, are
known in human and mice (69, 70). Among the cyclin family
proteins, cyclin A, cyclin B, cyclin D, and cyclin E are canonical
cyclins, which interact with cell-cycle-related CDKs and regulate
cell division (71, 72). These canonical cyclins regulate distinct
phases of cell cycle; cyclin A regulates S and G2 phases, cyclin
B regulates M phase, cyclin D regulates G1 phase, and cyclin E
regulates G1 and S phases (73–76).
Cyclin D1 is a member of cyclin D family, along with
cyclin D2 and cyclin D3. Overexpression of cyclin D1 in cells
results in a rapid progression from G1 to S phase, whereas
inhibition of cyclin D1 prevents the entry into S phase (77). The
overexpression of cyclin D1 in mouse increases the incidence
of carcinoma in the mammary gland and the liver (78, 79).
Correlation between elevated expression of cyclin D1 and various
cancers and their poor prognosis is also noted in human (80, 81)
and mouse (82).
To investigate the role of cyclin D1 in epithelial cells, Robles
et al. generated transgenic mice in that cyclin D1, encoded by
human CCND1 gene, was driven by bovine keratin 5 promoter
(53). Keratin 5 is primarily expressed in basal keratinocytes of
the skin epidermis. It was found that these keratin 5-driven
cyclin D1-transgenic (K5D1) mice exhibit epidermal hyperplasia
in the skin (53). The authors also found that the thymus
in K5D1 mice exhibit severe hyperplasia, which is apparent
by 14 weeks of age when age-associated thymic involution
is detectable in control mice, whereas the thymus in K5D1
mice at 2 weeks of age is comparable in size to that in
control mice (53). In the thymus, TEC progenitors and mTECs
highly express keratin 5 (54, 83), and both the cortical and
medullary regions are enlarged in the thymus of K5D1 mice
(53, 54).
The enlarged thymuses in K5D1 mice contain ∼100-fold
larger numbers of TECs compared with control C57BL/6
(B6) thymuses, and the cellularity of thymocytes in K5D1
mice reaches to ∼50-fold larger numbers of that in B6
mice (67, 84). In K5D1 mice, the cellularity of cTECs is
elevated similarly to that of mTECs, although keratin 5 is
predominantly detectable in mTECs but not cTECs (67). It
is possible that the increase in the number of cTECs is
at least in part due to cyclin D1-mediated promotion of
cell cycle in keratin 5-expressing TEC progenitors (54). It is
additionally possible that cell cycle progression within cTEC
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FIGURE 2 | Proteomic analysis of TECs isolated from enlarged thymus.
Volcano plot of TMT-based quantitative proteomes for cTECs and mTECs
isolated from keratin 5 promoter-driven cyclin D1-transgenic (K5D1) mice.
Detected proteins, which we have recently reported (67), are plotted as log2
fold changes (K5D1 cTECs / K5D1 mTECs) vs. –log10 P-values.
compartment is promoted in K5D1 mice, since a remarkably
elevated amount of cyclin D1 transcripts are detected in K5D1
cTECs (67). The signals provided by developing thymocytes
play an important role in the development of cTECs (19,
83). Indeed, hCD3ε transgenic mice, in which early thymocyte
development is primarily defective, do not exhibit thymic
hyperplasia even when they are crossed with K5D1 mice to
overexpress cyclin D1 in TECs (54). Thus, developing thymocytes
appear to contribute to the increase in TEC cellularity in
K5D1 mice.
K5D1 thymuses support thymocyte development similar
to B6 thymuses, as the proportion of developing thymocytes
subsets, including CD4−CD8−, CD4+CD8+, CD4+CD8−, and
CD4−CD8+ thymocytes in K5D1 mice is almost comparable
to that in B6 mice (67). However, mature CD4- or CD8-single
positive thymocytes identified as CD69−Qa2+ are accumulated
in the K5D1 thymus (84). This accumulation is possibly
due to unelevated amount of sphingosine-1-phosphate (S1P),
produced by unelevated number of endothelial cells in the
K5D1 thymus, because S1P plays an essential role in promoting
thymic egress of mature thymocytes (85). Indeed, in contrast
to thymocytes, which are ∼50-fold-elevated in cell number,
the increase of splenic T cell number in K5D1 mice is only
2- to 3-fold of that in B6 mice (67, 84). In addition to
the possible limitation in the machinery for thymic egress of
mature thymocytes, limited availability of cytokines, such as
Interleukin-7 (IL-7), to maintain peripheral T cells, may also
limit the cellularity of the peripheral T cell pool in K5D1
mice (86).
THYMIC EPITHELIAL CELLS IN CYCLIN
D1-MEDIATED ENLARGED THYMUS ARE
FUNCTIONALLY POTENT
The function of the thymus to produce self-protective T
cells and to instill their self-tolerance is chiefly mediated by
cTECs and mTECs, respectively. The capability of thymocyte
development in K5D1 mice suggests the functional equivalence
between K5D1 TECs and B6 TECs. cTECs uniquely express β5t-
containing thymoproteasome important for optimal production
of immunocompetent CD8+ T cells (87–89), whereas Aire
expressed in mTECs plays a role for the establishment of self-
tolerance in T cells (90). The enlarged K5D1 thymuses contain
β5t+ cTECs in the cortex and Aire+ mTECs in the medulla
(67). It was shown that β5t deficiency in K5D1 mice results in
the impaired generation of CD8+ T cells in the thymus, and
the loss of Aire in mTECs causes autoimmune inflammation
in various tissues, including the retinas and salivary glands,
in K5D1 mice (67). T cells generated in the K5D1 thymus
show a proliferative response to allogenic stimulation and are
unresponsive to synergic cells (67). T cells that express TCR
specific for a male specific H-Y antigen are positively selected
in the thymus of female K5D1 mice, whereas those T cells
are negatively selected in the thymus of male K5D1 mice (54).
Thus, cTECs and mTECs in the enlarged K5D1 thymus are
functionally competent to produce immunocompetent yet self-
tolerant T cells.
PROTEOMIC PROFILING OF THYMIC
EPITHELIAL CELLS ISOLATED FROM
CYCLIN D1 ENLARGED THYMUS
Isolation of cTECs and mTECs generally involves enzymatic
digestion of thymic tissues. Although the thymus in one postnatal
B6 mouse contains more than 1 × 106 cTECs and more than
1 × 106 mTECs, the number of either cTECs or mTECs isolated
from one B6 mouse is typically< 1× 104 cells (46, 47). However,
a large number of cells (typically more than 5 × 105 cells
per sample) are required for current mass spectrometry-based
technology of proteomic analysis, unlike transcriptomic analysis,
which can be carried out from small number of cells. Using the
enlarged thymus in K5D1 mice, it is possible to isolate ∼2 ×
105 cTECs and ∼2 × 105 mTECs from one mouse (67). These
relatively large numbers of cTECs and mTECs allow unbiased
proteomic analysis.
cTECs and mTECs isolated from K5D1 mice are qualified
for proteomic analysis, because RNA-sequencing-based
transcriptomic profiles of cTECs and mTECs are highly
similar between K5D1 mice and B6 mice (67). For example,
functionally relevant genes in mTECs, including Aire, Ccl21a,
and Tnfrsf11a (encoding RANK), as well as Aire-dependent and
Aire-independent tissue-restricted self-antigen genes are highly
detected in mTECs in an indistinguishable manner between
K5D1 mTECs and B6 mTECs (67). Similarly, functionally
relevant genes in cTECs, including Dll4 (encoding DLL4),
Psmb11 (encoding β5t), Prss16 (encoding thymus-specific serine
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protease or TSSP), and Ctsl (encoding cathepsin L), are highly
detected in cTECs in an indistinguishable manner between
K5D1 cTECs and B6 cTECs (67). Only a minor difference in
transcriptomic profiles between K5D1 TECs and B6 TECs is
the overexpression of cyclin D1 and cell-cycle-related genes
(67). Another minor difference detected between K5D1 TECs
and B6 TECs is the difference in the number of CD4+CD8+
thymocytes tightly associated with isolated cTECs (67). cTECs
form multicellular complexes that a single cTEC completely
envelops a variety number of CD4+CD8+ thymocytes (46, 91).
These multicellular complexes include thymic nurse cells, which
entirely encapsulate CD4+CD8+ thymocytes (91) and so cannot
be fully dissociated from encapsulated CD4+CD8+ thymocytes
by current technology for cTEC isolation (67). The number of
enclosed DP thymocytes per one isolated cTEC is smaller in
K5D1mice than B6 mice, so that transcriptomic profiles of K5D1
cTECs is less affected than those in B6 cTECs by the signals
derived from CD4+CD8+ thymocytes (67). Nevertheless, cTECs
and mTECs isolated from K5D1 mice are not only functionally
potent to produce immunocompetent and self-tolerant T cells
but also are highly similar in transcriptomic profiles, so that
cTECs and mTECs isolated from K5D1 mice are largely qualified
for proteomic profiling to better understand the biology of
cTECs and mTECs.
Tandem mass tag (TMT)-based mass spectrometry analysis
is a powerful technology for unbiased proteomics that enables
multiplex analysis of relative quantification of proteins (92). It
successfully quantified 5,753 protein species in total in cTECs and
mTECs isolated from K5D1 mice by the TMT-based quantitative
proteomic analysis (67). Similar to the transcriptomic profiles,
proteomic profiles show a sharp contrast between cTECs and
mTECs; 636 proteins, including β5t, TSSP, and CD83, which are
known to play an important role in cTECs, are significantly (p
< 0.05) higher in cTECs than mTECs, whereas 1,021 proteins,
including Aire, cathepsin S, and CD40, which are known to play
an important role in mTECs, are significantly (p < 0.05) higher
in mTECs than cTECs (Figure 2). It was noticed that secretory
proteins, including cytokines and chemokines, are removed from
isolated cTECs and mTECs during cell isolation procedures and
are undetectable in the proteomic profiles (67).
These proteomic profiles for cTECs and mTECs have led
to integrated analysis of proteomic and transcriptomic profiles
in cTECs or mTECs (67). Approximately 70% of molecules
detected in proteomic analysis of K5D1 TECs are detected in
transcriptomic profiles of B6 TECs, whereas ∼30% of molecules
detected in transcriptomic profiles of B6 TECs are detected
in proteomic analysis of K5D1 TECs (67). These overlapped
molecules include many molecules previously reported in TECs
and include molecules such as DCLK1, Avil, and Trmp5,
expressed by thymic tuft cells, a recently described subpopulation
of mTECs (64, 65, 67). Newly identified molecules include
cathepsin D and calpain 1, abundantly expressed in cTECs,
and cathepsin C, cathepsin H, and cathepsin Z, abundant
in mTECs (67). These proteases may play an important role
in processing self-antigens in cTECs and mTECs and in
enabling TCR repertoire selection in the thymus, in addition
to previously described β5t, TSSP, and cathepsin L in cTECs,
and cathepsin S in mTECs. The integrated analyses of K5D1
TECs further reveal that genetic loss of β5t specifically alters
the amount of individual proteasomal components in cTECs
but minimally affects proteomic and transcriptomic profiles in
cTECs (67).
It is interesting to note that proteomic profiles and
transcriptomic profiles do not provide a proportional correlation
between the amount of proteins and mRNAs in cTECs and
mTECs (67). It is possible that post-transcriptional turnover
of transcripts and post-translational turnover of proteins may
account for the disagreement between the abundance of mRNAs
and proteins (67). Thus, quantitative proteomic profiling of TECs
isolated from K5D1 mice has revealed a previously unknown
platform for further exploring molecular biology of TECs.
Propagation of mobilized cell lines that maintain functionally
relevant molecular expression profiles has not been successful for
cTECs or mTECs, so that the enlarged thymus provides a useful
source of large numbers of freshly isolated cTECs and mTECs,
not only for proteomic analysis but also for other analyses,
including metabolomic analysis and other biochemical analyses.
It is certainly important to identify MHC-associated self-peptides
presented by cTECs and mTECs, which induce positive and
negative selection of thymocytes to form an immunocompetent
yet self-tolerant TCR repertoire.
WHY DOES THE THYMUS INVOLUTE?
Although the immunological consequences of thymic involution
have potential disadvantages to the elderly, thymic involution
may have evolved for the benefit of the aging host. However,
such benefits may be less favorable given current lifespans. One
hypothesis is that reduced thymic activity would protect against
autoimmunity (93). Seemingly at odds with this idea, accelerated
thymic involution in young mice can disrupt central immune
tolerance, by perturbed negative selection resulting in the release
of autoreactive T cells into the periphery (94, 95). However,
experimental systems could conceivably differ from naturally
occurring thymic involution. Separately, it is known that some
T cells in elderly mice that express markers of self-recognition
are selectively retained during aging (96, 97). This could offer
an explanation as to why the elderly have a predisposition to
certain autoimmune conditions (94, 97), that could be mitigated
by thymic involution. Overall, considerably more work is needed
to determine whether the elderly are indeed at increased risk for
autoimmunity, and whether reduced thymic activity may have
any protective function.
It has also been suggested the involution process may
conserve energy. The majority of developing thymocytes die
during the stringent selection process in the thymus, where over
90% are estimated to undergo cell death (98), and the long-
lived peripheral T cells established in early life can undergo
homeostatic proliferation to maintain their numbers (99). Thus,
energy may be best diverged into other biological processes after
the T cell pool is established in early life (6).
Another possibility is that the reduced numbers of naïve T
cells may also reduce the incidence of leukemias (6). Others have
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suggested the diminished numbers of recent thymic emigrants
from the involuting thymus forces enhanced selection of the
peripheral T cell repertoire and conserves the persistence of long-
lived memory T cells in the periphery which are favorable to
the host in old age (99, 100). If such theories are correct and
involution is beneficial to the host, approaches to restore thymic
size and function in old people become questionable. Therefore, a
better understanding of whether thymic involution is favorable to
the host will establish if thymic regeneration would be beneficial
as a clinical approach.
CONCLUSIONS AND PERSPECTIVES
T cell-mediated immunity is essential throughout life. However,
the thymus, where T cells are generated, involutes rapidly in early
life. Postnatal thymic involution is attributable to TECs rather
than thymocytes. In this review, we summarize recent findings
that the decline in a fetal-specific transcriptional program of
TECs controls the size of the postnatal thymus and that cTEC
morphology is altered during postnatal thymic involution. These
findings provide novel insights into molecular and cellular
mechanisms in TECs that control thymus size during involution.
Thymic involution results in reduced thymocyte development
and reduced numbers of naïve T cells and so is predicted
to result in immunological disadvantages, including increased
incidence in infectious disease and delayed T cell reconstitution
after hematopoietic stem cell transplantation (101). Therefore,
prevention of thymic involution and regeneration of thymic
function is likely to be useful for the maintenance and
improvement of T-cell-mediated immune homeostasis. On the
other hand, the increase in the number of peripheral T cells
is limited in mice that carry an enlarged thymus, suggesting
that merely enhancing the number of TECs and the size
of the thymus is insufficient to expand the peripheral T
cell pool.
In this review, we also summarize how the development of
large thymus models are useful tools for understanding TEC
biology. This includes the versatility of enlarged K5D1 thymi
for biochemical analysis, including proteomic profiling of TECs.
Using such useful tools, we can examine whether functional
senescence is induced in enlarged thymi and how counter-
involution in aged mice may impact health. Moreover, such
models could give novel targets for manipulation to prevent or
reverse thymus atrophy.
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